Critical Reviews in Oncology / Hematology
Volume 74, Issue 1 , Pages 40-60, April 2010

The role of immunity in elderly cancer

  • Lucia Malaguarnera

      Affiliations

    • Department of Biomedical Sciences, University of Catania, Italy
  • ,
  • Erika Cristaldi

      Affiliations

    • Department of Senescence, Urological and Neurological Sciences, University of Catania, Italy
  • ,
  • Mariano Malaguarnera

      Affiliations

    • Department of Senescence, Urological and Neurological Sciences, University of Catania, Italy
    • Corresponding Author InformationCorresponding author at: Department of Senescence, Urological and Neurological Sciences, Azienda Ospedaliera Cannizzaro, via Messina 829, 95124 Catania, Italy. Tel.: +39 095 7262008; fax: +39 095 7262011.

Accepted 5 June 2009. published online 06 July 2009.

Abstract 

The increased incidence of malignancies in elderly patients living in industrialized countries has led to both identify the causes that alter the normal homeostatic balance in elderly and designate the specific treatments. The progressive decline of the immune system (immunosenescence) involving cellular and molecular alterations impact both innate and adaptive immunity. The immunosenescence leads to increased incidence of infectious diseases morbidity and mortality as well as heightened rates of other immune disorders such as autoimmunity, cancer, and inflammatory conditions. Here, we summarize the knowledge on the major changes in the immune system associated with aging in primary lymphoid organs as well as a description of molecular mechanisms, and the impact on cancer development.

Keywords: Cytokines, Chemokines, Immunosenescence, Tumorigenesis, Ageing, Lymphocytes, Haematopoietic stem cells

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1040-8428(09)00122-X

doi:10.1016/j.critrevonc.2009.06.002

Critical Reviews in Oncology / Hematology
Volume 74, Issue 1 , Pages 40-60, April 2010